Results 31 to 40 of about 790 (151)

Fluralaner treatment of chickens kills the southern house mosquito, Culex quinquefasciatus. [PDF]

open access: yesMed Vet Entomol
Chickens treated with fluralaner, fenbendazole or ivermectin did not repel Culex quinquefasciatus from feeding. The mortality of Culex quinquefasciatus feeding on fluralaner‐treated chickens was significantly higher than that of those fed on control chickens at 3 and 7 days post‐treatment.
Knape K   +7 more
europepmc   +2 more sources

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis

open access: yesParasites & Vectors, 2022
Background Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the ...
Nadja Rohdich, Leon Meyer, Frank Guerino
doaj   +1 more source

G3'MTMD3 in the insect GABA receptor subunit, RDL, confers resistance to broflanilide and fluralaner.

open access: yesPLoS Genetics, 2023
Meta-diamides (e.g. broflanilide) and isoxazolines (e.g. fluralaner) are novel insecticides that target the resistant to dieldrin (RDL) subunit of insect γ-aminobutyric acid receptors (GABARs).
Yichi Zhang   +10 more
doaj   +1 more source

Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats [PDF]

open access: yesParasites & Vectors, 2017
The efficacy of fluralaner for the treatment of Otodectes cynotis infestations in dogs and cats was evaluated after oral (dogs) or topical administration (dogs and cats). Twenty-four dogs and sixteen cats were experimentally infested with O. cynotis and randomly allocated to equal sized groups (n = 8/group).
Taenzler, Janina   +4 more
openaire   +2 more sources

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

open access: yesParasites & Vectors, 2015
Background Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose.
Feli M. Walther   +2 more
doaj   +1 more source

Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment

open access: yesParasites & Vectors, 2014
Background Fluralaner, a novel isoxazoline, has both acaricidal and insecticidal activity through potent blockage of GABA- and L-glutamate-gated chloride channels.
Heike Williams   +4 more
doaj   +1 more source

Topical, contact, and oral susceptibility of adult Culicoides biting midges (Diptera: Ceratopogonidae) to fluralaner

open access: yesParasites & Vectors, 2023
Background Culicoides biting midges (Diptera: Ceratopogonidae) are economically important blood-feeding pests closely associated with livestock production. They are the principal vectors of two hemorrhagic disease viruses affecting both wild and domestic
Blythe E. Lawson, Emily G. McDermott
doaj   +1 more source

Effect of fluralaner on the biology, survival, and reproductive fitness of the neotropical malaria vector Anopheles aquasalis

open access: yesMalaria Journal, 2023
Background Reducing mosquito abundance or interfering with its ability to support the parasite cycle can help to interrupt malaria in areas of significant risk of malaria transmission.
João Arthur Alcântara   +13 more
doaj   +1 more source

Effects of Feed Intake and Water Hardness on Fluralaner Pharmacokinetics in Layer Chickens

open access: yesJournal of Veterinary Science, 2022
Fluralaner is a novel drug belonging to the isoxazoline class that acts on external parasites of domestic animals. It is used systemically via drinking water, especially against red poultry mite in layer chickens. Fluralaner is frequently used in layers infected with D. gallinae. However, no study to date has investigated the effects of feed intake and
Ataman Bilge Sari   +6 more
openaire   +2 more sources

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats

open access: yesParasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas
Nadja Rohdich   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy